• End points of translational research clinical trials
  • Prognostic and predictive tumor markers
  • The molecular pathology of non-smoker lung cancer pts
  • Gender discrepancies in lung cancer
  • NSCLC driver oncogenes
  • EGFR mutation heterogeneity
  • Newer generation TKIs inhibitors
  • The Met, K-ras and mTOR/PI3K pathways

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Learning Objectives & Topics

5th Lung Cancer Network «From the Bench to the Bedside»

4th Lung Cancer Network «From the Bench to the Bedside»

4th Lung Cancer Network «From the Bench to the Bedside»

Congress Secretariat

 logo ets copy

E.T.S. Events & Travel Solutions S.A.
154 El. Venizelou Str
N. Smyrni, Athens, Greece, 171 22
Tel.: +30 210 98 80 032
Fax.: +30 210 98 81 303
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Website: www.events.gr

Scroll to top